Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
Lockdowns instituted due to the COVID-19 pandemic could have brought about exacerbated immune responses in people living with ...
A University of Denver virologist and biophysicist is one step closer to understanding how HIV spreads once it enters the ...
Top articles about HIV this year included effects of HIV on tooth loss and cardiac surgery, caregiver experiences, and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback